| Pharmaceutical active ingredients: |
| Nimesulide |
| Available forms, composition and doses of Mesulid: |
| N / A |
| Mesulid medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX17 - NimesulideM02AA26 - Nimesulide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mersyndol Forte | Acetaminophen; Codeine Phosphate; Doxylamine Succinate | Sanofi-Aventis |
| Mersyndol with Codeine | Acetaminophen; Codeine Phosphate; Doxylamine Succinate | Sanofi-Aventis |
| Meruvax | Rubella Virus Vaccine live attenuated Wistar RA 27 / 3 Strain | Sanofi-Aventis; Pro Vaccine |
| Mesite-XR | Metformin Hydrochloride | Sanofi-Aventis |
| M-Eslon | Morphine Sulfate | Sanofi-Aventis; Egis; Ethypharm; Grunenthal; Multichem, New Zealand; Primal Chemical; ProMed CS Praha |
| Metahydrin | Trichlormethiazide | Sanofi-Aventis |
| Met-Amaryl | Glimepiride; Metformin Hydrochloride | Sanofi-Aventis |
| Metamide | Metoclopramide Hydrochloride | Sanofi-Aventis; Pacific Pharmaceuticals |
| Metatensin | Reserpine; Trichlormethiazide | Sanofi-Aventis |
| Metatensin N2 | Reserpine; Trichlormethiazide | Sanofi-Aventis |